Control of urinary risk factors of stone formation by Salvadora persica in experimental hyperoxaluria

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 32, Issue 9, 2010, Pages 623-629

  Geetha, K ^a,b   Manavalan, R ^c   Venkappayya, D ^b  

^a Ultra College of Pharmacy   (India)

^b SASTRA UNIVERSITY   (India)

^c ANNAMALAI UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CALCIUM; CREATININE; ETHYLENE GLYCOL; MAGNESIUM; OXALIC ACID; PHOSPHATE; PLANT EXTRACT; SALVADORA PERSICA EXTRACT; SODIUM; UNCLASSIFIED DRUG; UREA; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG ACTIVITY; FEMALE; HISTOPATHOLOGY; HYPEROXALURIA; KIDNEY INJURY; LD 50; MALE; MOUSE; NONHUMAN; RAT; RISK FACTOR; SALVADORA PERSICA; SALVADORACEAE; TOXICITY TESTING; UROLITHIASIS;

ACUTE TOXICITY TESTS; ANIMALS; CREATININE; DISEASE MODELS, ANIMAL; ETHYLENE GLYCOL; FEMALE; KIDNEY CALCULI; MALE; MICE; OXALATES; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, WISTAR; RISK FACTORS; SALVADORACEAE; SOLVENTS; UROLITHIASIS;

EID: 79954509209     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2010.32.9.1549114     Document Type: Article

References (42)

1. Bek-Jensen, H., Tiselius, H.G. Repeated urine analysis in patients with calcium stone disease. Eur Urol 1998, 33(3): 323-32.
2. Rengaraju, M., Selvam. R. Role of citrate as an inhibitor of calcium oxalate stone formation in experimental urolithiasis. Arogya J Health Sci 1987, 13: 49-54.
3. Lee, Y.H., Huang, W.C., Huang, J.K., Chang, L.S. Testosterone enhances whereas estrogen inhibits calcium oxalate stone formation in ethylene glycol treated rats J Urol 1996, 156(2, Pt.1): 502-5.
4. Prince, C.L., Scardino, P.L. A statistical analysis of ureteral calculi. J Urol 1960, 83: 561-5.
5. Halabe, A., Sperling, O. Uric acid nephrolithiasis. Miner Electrolyte Metab 1994, 20(6): 424-31.
6. Aeckart, K.S.J., Schroder F.H. Effect of extracorporeal shock wave lithotripsy (ESWL) on renal tissue. A review. Urol Res 1989, 17(1): 3-7.
7. http://www.flowersofindia.net/catalogs/slides/Toothbrush%20Tree.html.
8. Nadkarni, K.M. Indian Materia Medica, 3rd Ed. Popular Book Depot: Mumbai 1976, 371-2.
9. Monforte, M.T., Miceli, N., Mondello, M.R., Sanogo, R., Rossitto A., Galati, E.M. Antiulcer activity of Salvadora persica on experimental ASA-induced ulcer in rats. Ultrastructural modifications. Pharm Biol 2001, 39(4): 289-92.
10. Al, S.D.A.A., Al, B.N.H. A study of the antimicrobial activity of the miswak ethanolic extract in vitro. Biomed Lett 1996, 53(212): 225-38.
11. Gazi, M., Lambourne, A, Chagla, A. The antiplaque effect of toothpaste containing Salvadora persica compared with chlorhexidine gluconate: A pilot study. Clin Preventive Dent 1987, 9(6): 3-8.
12. El Mostehy, M.R., Al-Jassem, A.A, Al-Yassin, I.A. et al. Miswak as an oral health device: Preliminary chemical and clinical evaluation. Hamdard 1983, 26: 41-50.
13. Akhtar, M., Ajmal, M. Significance of chewing sticks (miswak) in oral hygiene from a pharmacological view point. J. Pakistan Med Assn 1981, 4: 89-94.
14. Ezmirly, S.T., Cheng, J.C., Wilson, S.R. Saudi Arabian medicinal plants: Salvadora persica. Planta Med 1979, 35(2): 191-2.
15. Kokate, C.K. Practical Pharmacognosy. Vallabh Prakashan: Delhi 2004, 107.
16. OECD guidelines for testing of chemicals. http://iccvam.niehs.nih.gov/SuppDocs/FedDocs/OECD/OECD_GL423.pdf.
17. Atmani, F., Slimani, Y., Mimouni, M., Hacht, B. Prophylaxis of calcium oxalate stones by Herniaria hirsuta on experimentally induced nephrolithiasis in rats. BJU Int 2003, 92(1): 137-140.
18. Medeiros, D.M., Mustafa, M.A. Proximate composition, mineral content and fatty acids of cat fish (Ictalurus punctatus rafinesque) for different seasons and cooking methods. J Food Sci 1985, 50: 585-8.
19. Fiske, C.H., Subbarow, Y. The colorimetric determination of phosphorus. J Biol Chem 1925, 66: 375-81.
20. Hodgkinson, A., Williams. A. An improved colorimetric procedure for urine oxalate. Clin Chim Acta 1972, 36: 127-32.
21. Ballentine, R., Burford, D.D. In: Methods in Enzymology. S.P. Colowick, N.O. Kaplan. (Eds). Academic Press: New York 1957, 3: 1002-35.
22. Raghuramulu, N., Madhavan, N.K., Kayanasundaram, S. A Manual of Laboratory Techniques, First Ed. National Institute of Nutrition: Hyderabad 1983, 42.
23. Caraway, W.T. Uric acid. In: Seligson, D. (Ed). Standard Methods in Clinical Chemistry. Academic Press: New York 1963, 4239.
24. Chow, F.C., Dysent, I.M., Hamer, D.W., Udall, H.R. Control of oxalate urolithiasis by DL-alanine. Invest Urol 1975, 13: 113-7.
25. Soundararajan, P., Mahesh, R., Ramesh, T., Begum, V.H. Effect of Aerva lanata on calcium oxalate urolithiasis in rats. Ind J Exp Biol 2006, 44(12): 981-6.
26. Vermeulen, C.W. Experiments on causation of urinary calculi. In: Essays in Experimental Biology. University of Chicago Press: Chicago 1962, 253-69.
27. Prasad, K.V.S.R.G., Bharathi, K., Srinivasan K.K. Evaluation of Musla (parasidica linn cullivar)"Puttubale" stem juice for antilithiatic activity in albino rats. Ind J Physiol Pharmacol 1993, 37(4): 337-41.
28. Malini, M.M., Baskar, R., Varalakshmi, P. Effect of lupeol, a pentacyclic triterpene on urinary enzyme in hyperoxaluric rats. Jpn J Med Sci Biol 1995, 48(5-6): 211-20.
29. Schladt, L., Ivens, I., Karbe, E., Ruhl-Fehlert, C., Bomhard, E. Subacute oral toxicity of tetraethylene glycol and ethylene glycol administration in Wistar rats. Exp Toxicol Pathol 1998, 50(3): 257-65.
30. Underwood, F., William, M., Bennet, M.D. Ethylene glycol intoxication. Prevention of renal failure by aggressive management. JAMA 1973, 226: 1453-4.
31. Scheinman, J.I. Primary hyperoxaluria. Miner Electrol Metabol 1994, 20: 340-51.
32. Tisselius, H.G. Solution chemistry of supersaturation. In: Kidney Stones: Medical and Surgical Management. F.L. Coe, M.J. Favus. C.Y.C Pak, J.H. Parks, G.M. Preminger (Eds). Lippincott-Raven: Philadelphia 1996, 3-32.
33. Rebertson, W.G., Peacock, M. The cause of idiopathic calcium stone disease: Hypercalciuria or hyperoxaluria? Nephron1980, 26(3): 105-10.
34. Lemann, J. Jr., Worcestor, E.M., Gray, R.W. Hypercalciuria and stones. Am J Kidney Dis 1991, 17(4): 386-91.
35. Roger, K., Low, M.D., Stoller, M.L. Uric acid nephrolithiasis. Urol Clin North Am 1997, 24(1): 135-48.
36. Ryall, R.L., Harnet, R. Marshall, V.R. The effect of urine pyrophosphate, citrate, magnesium, and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 1981, 112(3): 349-56.
37. Grases, F., Genestar, C., Comte, A., March, P., Costa-Bauza, A. Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulfate in calcium oxalate urolithiasis. Br J Urol 1989, 64(3): 235-7.
38. Khan, S.R. Animal models of kidney stone formation: An analysis. World J Urol 1997, 15(4): 236-43.
39. Ghodkar, P.B. Chemical test in kidney disease. In: Textbook of Medical Laboratory Technology, First Ed. Bhalani Publishing House: Mumbai, India 1994, 118-32.
40. Sumathi, R., Jayanthi, S., Kalpanadevi, V., Varalakshmi, P. Effect of DLlipoic acid on tissue lipid peroxidation and antioxidant systems in normal and glycollate treated rats. Pharmacol Res 1993, 27(4): 309-18.
41. Ernster, L., Nordenbrand, K. Oxidation and phosphorylation. In: Methods in Enzymology, Vol. 10. W.E. Ronald, E.P. Maynard (Eds.). Academic Press: New York 1967, 574-80.
42. Tripathi, Y.B., Shukla. S., Tripathi, P. Medicinal plants of Rasayana group as antioxidants. In: International Seminar on Free Radicals Mediated Diseases and Ayurveda. Faculty of Ayurveda. IMS. BHU (September 2-4, Varanasi, India) 1996, PA 33.